Corteva

Indianapolis – September 17, 2026 -- Corteva's Board of Directors has approved the separation of the company's seed operating segment into a new independent, publicly traded entity, Vylor Inc., with the stock distribution scheduled for October 1, 2026.

Board declares pro rata stock dividend of Vylor shares

Corteva stockholders of record as of the close of business on September 24, 2026, will receive one share of Vylor common stock for every Corteva share held. Any fractional shares will be settled in cash, and the distribution is intended to be tax-free to Corteva stockholders for U.S. federal income tax purposes, excluding cash received for fractional shares.

Wilmington, Del. – September 15, 2026 -- DuPont, together with The Chemours Company and Corteva Inc., has agreed to pay $455 million over 15 years to resolve PFAS litigation brought by the State of North Carolina and 11 local entities near the companies' Fayetteville Works facility.

The settlement carries a net present value of approximately $355 million, split among the three chemical makers, and covers claims tied to historical discharges from Fayetteville Works as well as separate state allegations of PFAS contamination linked to aqueous film forming foam (AFFF) use.

DuPont's exposure is capped near $126 million on a pre-tax present-value basis

Of that amount, 44% will be reimbursed by Qnity Electronics, and DuPont says the remaining liability is materially covered by existing accruals, limiting the hit to future earnings.

Wilmington, Del. – September 15, 2026 -- The Chemours Company, along with DuPont de Nemours and Corteva, has agreed to pay $455 million over 15 years to settle PFAS-related litigation brought by the State of North Carolina and 11 local entities near the company's Fayetteville Works facility.

Chemours' share totals approximately $180 million on a net present value basis

Under a January 2021 memorandum of understanding, Chemours is responsible for 50% of settlement payments, with DuPont and Corteva covering the remaining half. Chemours said its portion is fully covered by existing accruals, with expected payments of approximately $50 million over the next twelve months.

Indianapolis – September 13, 2026 -- Corteva (NYSE: CTVA) and Belgium-based Globachem N.V. have signed a definitive agreement to launch a 50/50 joint venture aimed at developing and delivering new crop protection solutions for farmers in Europe and the Americas, with the deal expected to close in the fourth quarter of 2026.

Joint venture will pool late-stage pipeline technology from both parent companies

The independently operated JV will draw on late-pipeline to commercial-stage technology from Corteva and Globachem to develop, register and market new products. Resulting solutions may be commercialized independently by one or both parent companies once ready.

New products targeted for launch in the early 2030s

The venture builds on an existing multi-year partnership between the two companies. New solutions are expected to reach the market in the early 2030s through established commercial channels.